<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04078620</url>
  </required_header>
  <id_info>
    <org_study_id>4606/28-5-2018</org_study_id>
    <nct_id>NCT04078620</nct_id>
  </id_info>
  <brief_title>Risk Factors for Potential Drug -Drug Interactions: Study in Surgical Intensive Care Unit -Zagazig University Hospitals.</brief_title>
  <official_title>Risk Factors for Potential Drug -Drug Interactions: Study in Surgical Intensive Care Unit -Zagazig University Hospitals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Drug drug interactions is frequent in critically ill patients due to polypharmacy, different
      drug groups and prolonged ICU or hospital stay
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This cross sectional study was conducted in Surgical ICU, zagazig University Hospital for
      6months period.

      Demographic data (age, gender),clinical history data (main diagnosis, ICU stay in days,
      transfer from emergency room or other departments, on mechanical ventilation or not, state of
      consciousness
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 15, 2018</start_date>
  <completion_date type="Actual">April 20, 2019</completion_date>
  <primary_completion_date type="Actual">January 15, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Severity of Drug interactions by Lexicomp interactions application</measure>
    <time_frame>6months period</time_frame>
    <description>Lexicomp interactions classified As:
A(no known interactions) B(no action needed) C(monitor therapy) D(consider therapy modification) X (avoid combination)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Severity of Drug interactions by Medescape interactions checker:</measure>
    <time_frame>6months period</time_frame>
    <description>Interactions classified with Medescape interactions checker as :(contraindicated, serious use alternative, monitor closely,minor)</description>
  </primary_outcome>
  <enrollment type="Actual">120</enrollment>
  <condition>Drug Interaction</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Survey for drug drug interactions on medscape and lexicomp applications</intervention_name>
    <description>Survey for drug drug interactions on Medscape and Lexicomp interaction checker applications</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients admitted to Surgical ICUs, zagazig University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients admitted to Surgical ICUs for six months period

        Exclusion Criteria:

          -  less than one day admission to ICU,not completed data
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liza Shallouf</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heba Matar</last_name>
    <role>Study Director</role>
    <affiliation>Zagazig University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Liza Elsayed Ali</name>
      <address>
        <city>Zagazig</city>
        <state>Sharquia</state>
        <zip>33735</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>August 25, 2019</study_first_submitted>
  <study_first_submitted_qc>September 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 6, 2019</study_first_posted>
  <last_update_submitted>September 1, 2019</last_update_submitted>
  <last_update_submitted_qc>September 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Liza Elsayed Ali soliman shallouf</investigator_full_name>
    <investigator_title>Principle investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All data could be shared</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>For indefinite time</ipd_time_frame>
    <ipd_access_criteria>Easy, direct information are available for other researchers</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

